Likely to go down tomorrow as the impatient move on.
News to me: no interim analysis on PegH - results likely to take years.
Long and strong if a little bored
Cannot definitively say there will be an interim analysis now before the study has even begun. Essentially, Helen said we will wait and see depending on the study results.
Yes, they can and have. That has to be agreed upon and planned out before the start of the trial. Torley and Frost have said no interim analysis. However, I don't think it is a blinded trial.
it will come soon - this quarter - so within next few weeks. In the same period, we should also see EMA approval for Mabthera (including $10M milestone payment from Roche), and possibly partnership updates, etc.